Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10669486rdf:typepubmed:Citationlld:pubmed
pubmed-article:10669486lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:10669486lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:10669486lifeskim:mentionsumls-concept:C0027882lld:lifeskim
pubmed-article:10669486lifeskim:mentionsumls-concept:C0030532lld:lifeskim
pubmed-article:10669486lifeskim:mentionsumls-concept:C1705480lld:lifeskim
pubmed-article:10669486lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:10669486lifeskim:mentionsumls-concept:C0442805lld:lifeskim
pubmed-article:10669486lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:10669486lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:10669486pubmed:issue2lld:pubmed
pubmed-article:10669486pubmed:dateCreated2000-4-7lld:pubmed
pubmed-article:10669486pubmed:abstractTextThis investigation used an in vitro hypothalamic brain slice preparation and whole cell and perforated-patch recording to examine the response of magnocellular neurons in hypothalamic paraventricular nucleus (PVN) to bath applications of vasopressin (VP; 100-500 nM). In 22/38 cells, responses were characterized by an increase in the frequency of bicuculline-sensitive inhibitory postsynaptic potentials or currents with no detectable influence on excitatory postsynaptic events. Perforated-patch recordings confirmed that VP did not have an effect on intrinsic membrane properties of magnocellular PVN neurons (n = 17). Analysis of intrinsic membrane properties obtained with perforated-patch recording (n = 23) demonstrated that all of nine VP-sensitive neurons showed a rebound depolarization after transient membrane hyperpolarization from rest. By contrast, 12/14 nonresponding neurons displayed a delayed return to resting membrane potentials. Recordings of reversed inhibitory postsynaptic currents with chloride-loaded electrodes showed that responses to VP persisted in media containing glutamate receptor antagonists but were abolished in the presence of tetrodotoxin. In addition, responses were mimicked by vasotocin [Phe(2), Orn(8)], a selective V(1a) receptor agonist, and blocked by [beta-Mercapto-beta, beta-cyclopentamethylenepropionyl(1),O-Me-Tyr(2), Arg(8)]-VP (Manning compound), a V(1a)/OT receptor antagonist. Neither [deamino-Cys(1),Val(4),D-Arg(8)]-VP, a selective V(2) receptor agonist, nor oxytocin were effective. Collectively, the results imply that VP acts at V(1a) receptors to excite GABAergic neurons that are presynaptic to a population of magnocellular PVN neurons the identity of which features a unique rebound depolarization. Endogenous sources of VP may be VP-synthesizing neurons in suprachiasmatic nucleus, known to project toward the perinuclear regions of PVN, and/or the magnocellular neurons within PVN.lld:pubmed
pubmed-article:10669486pubmed:languageenglld:pubmed
pubmed-article:10669486pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10669486pubmed:citationSubsetIMlld:pubmed
pubmed-article:10669486pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10669486pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10669486pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10669486pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10669486pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10669486pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10669486pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10669486pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10669486pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10669486pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10669486pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10669486pubmed:statusMEDLINElld:pubmed
pubmed-article:10669486pubmed:monthFeblld:pubmed
pubmed-article:10669486pubmed:issn0022-3077lld:pubmed
pubmed-article:10669486pubmed:authorpubmed-author:RenaudL PLPlld:pubmed
pubmed-article:10669486pubmed:authorpubmed-author:BuijsR MRMlld:pubmed
pubmed-article:10669486pubmed:authorpubmed-author:RuijterJ MJMlld:pubmed
pubmed-article:10669486pubmed:authorpubmed-author:HermesM LMLlld:pubmed
pubmed-article:10669486pubmed:authorpubmed-author:KlopAAlld:pubmed
pubmed-article:10669486pubmed:issnTypePrintlld:pubmed
pubmed-article:10669486pubmed:volume83lld:pubmed
pubmed-article:10669486pubmed:ownerNLMlld:pubmed
pubmed-article:10669486pubmed:authorsCompleteYlld:pubmed
pubmed-article:10669486pubmed:pagination705-11lld:pubmed
pubmed-article:10669486pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10669486pubmed:meshHeadingpubmed-meshheading:10669486...lld:pubmed
pubmed-article:10669486pubmed:meshHeadingpubmed-meshheading:10669486...lld:pubmed
pubmed-article:10669486pubmed:meshHeadingpubmed-meshheading:10669486...lld:pubmed
pubmed-article:10669486pubmed:meshHeadingpubmed-meshheading:10669486...lld:pubmed
pubmed-article:10669486pubmed:meshHeadingpubmed-meshheading:10669486...lld:pubmed
pubmed-article:10669486pubmed:meshHeadingpubmed-meshheading:10669486...lld:pubmed
pubmed-article:10669486pubmed:meshHeadingpubmed-meshheading:10669486...lld:pubmed
pubmed-article:10669486pubmed:meshHeadingpubmed-meshheading:10669486...lld:pubmed
pubmed-article:10669486pubmed:meshHeadingpubmed-meshheading:10669486...lld:pubmed
pubmed-article:10669486pubmed:meshHeadingpubmed-meshheading:10669486...lld:pubmed
pubmed-article:10669486pubmed:meshHeadingpubmed-meshheading:10669486...lld:pubmed
pubmed-article:10669486pubmed:meshHeadingpubmed-meshheading:10669486...lld:pubmed
pubmed-article:10669486pubmed:meshHeadingpubmed-meshheading:10669486...lld:pubmed
pubmed-article:10669486pubmed:meshHeadingpubmed-meshheading:10669486...lld:pubmed
pubmed-article:10669486pubmed:meshHeadingpubmed-meshheading:10669486...lld:pubmed
pubmed-article:10669486pubmed:meshHeadingpubmed-meshheading:10669486...lld:pubmed
pubmed-article:10669486pubmed:meshHeadingpubmed-meshheading:10669486...lld:pubmed
pubmed-article:10669486pubmed:meshHeadingpubmed-meshheading:10669486...lld:pubmed
pubmed-article:10669486pubmed:meshHeadingpubmed-meshheading:10669486...lld:pubmed
pubmed-article:10669486pubmed:meshHeadingpubmed-meshheading:10669486...lld:pubmed
pubmed-article:10669486pubmed:meshHeadingpubmed-meshheading:10669486...lld:pubmed
pubmed-article:10669486pubmed:year2000lld:pubmed
pubmed-article:10669486pubmed:articleTitleVasopressin increases GABAergic inhibition of rat hypothalamic paraventricular nucleus neurons in vitro.lld:pubmed
pubmed-article:10669486pubmed:affiliationNetherlands Institute for Brain Research, 1105 AZ Amsterdam, The Netherlands.lld:pubmed
pubmed-article:10669486pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10669486pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:10669486pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10669486lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10669486lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10669486lld:pubmed